BCM
EXAS

Bluefin Capital Management’s Exact Sciences EXAS Stock Holding History

Bluefin Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,100
Closed -$18.8K – 317
2022
Q4 		$18.8K Hold
17,100
– – ﹤0.01% 323
2022
Q3 		$10K Buy
+17,100
New +$705K ﹤0.01% 463

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Bluefin Capital Management's EXAS Position: Q1 2023 in Review

Bluefin Capital Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 6,000 shares — an estimated $297K sold.

Bluefin Capital Management first reported a position in EXAS in Q3 2019 and held it in 2 quarters. The position peaked at $297K in Q4 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Bluefin Capital Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Bluefin Capital Management sold 6,000 Exact Sciences shares in Q1 2023, an estimated $297K.
  • Bluefin Capital Management first reported a position in Exact Sciences in Q3 2019 and held it in 2 quarters.
  • Bluefin Capital Management's Exact Sciences position peaked at $297K in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Bluefin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.